000 01739 a2200469 4500
005 20250516221733.0
264 0 _c20151028
008 201510s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep05511
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChiang, Kun-Chun
245 0 0 _aCisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
_h[electronic resource]
260 _bScientific reports
_cJul 2014
300 _a5511 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aImmediate-Early Proteins
_xmetabolism
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aProtein Serine-Threonine Kinases
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
650 0 4 _aTumor Suppressor Proteins
_xmetabolism
650 0 4 _aNF-kappaB-Inducing Kinase
700 1 _aTsui, Ke-Hung
700 1 _aChung, Li-Chuan
700 1 _aYeh, Chun-Nan
700 1 _aFeng, Tsui-Hsia
700 1 _aChen, Wen-Tsung
700 1 _aChang, Phei-Lang
700 1 _aChiang, Hou-Yu
700 1 _aJuang, Horng-Heng
773 0 _tScientific reports
_gvol. 4
_gp. 5511
856 4 0 _uhttps://doi.org/10.1038/srep05511
_zAvailable from publisher's website
999 _c23968896
_d23968896